drugset / Trial / NCT00999401
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A study of sequential administration of oral sapacitabine and oral Seliciclib in patients with advanced solid tumors.
Timeline
- Start
- 2009-04
- Primary completion
- 2019-07-16
- Completion
- 2019-08-13
Publications
- Results Shapiro GI, et al. Responses to sequential sapacitabine and seliciclib in patients with BRCA-deficient solid tumors. Cancer Res April 15, 2013 73; LB-202.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seliciclib | Small molecule | — | Oral |
| Subject | sapacitabine | Small molecule | — | Oral |